Results 141 to 150 of about 10,221 (208)

Secretory vesicle and cell surface markers for human endocrine pancreatic and pituiary tumors [PDF]

, 1992
Gratzl, Manfred, Gratzl, O., Lahr, G., Langley, K., Vereczkey, C.   +4 more
core   +1 more source

Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma. [PDF]

Cureus
Alkundi A, Momoh R.
europepmc   +1 more source

Clinical indications and proper use of Visceral Adiposity Index. [PDF]

, 2013
Amato, M., Giordano, C.
core   +1 more source

Giant Prolactinoma Resistant to High-Dose Cabergoline in a Young Male Lost to Follow-Up. [PDF]

Cureus
Das A, Rummun MA, Shams A, Salman A.
europepmc   +1 more source

Cabergoline-induced prolactinoma treatment and subsequent estrogen-driven vascular smooth muscle tumorigenesis in a middle-aged female: A case report. [PDF]

Int J Surg Case Rep
Cintrón-Cartagena K, Christian-Colón G, Ortiz-Figueroa R, Vélez-Alvarado F, Torres-Milán I, Ruiz-Deyá G.   +5 more
europepmc   +1 more source

Hyperprolactinemia in Older Adults: A Narrative Review of Distinct Clinical Challenges and Management Strategies. [PDF]

Cureus
Quimbayo-Cifuentes AF.
europepmc   +1 more source

Long-term survival in a patient with metastatic prolactinoma: a 12-year follow-up. [PDF]

Proc (Bayl Univ Med Cent)
Hlavinka WJ, Mbilinyi RH, Sontam TR, Mantilla EC, Mella DB.   +4 more
europepmc   +1 more source

Autonomic balance and cardiovascular hemodynamic function in men with prolactinoma. [PDF]

Front Endocrinol (Lausanne)
Włochacz A, Krzesiński P, Wierzbowski R, Uziębło-Życzkowska B, Witek P, Zieliński G, Kazimierczak A, Banak M, Włochacz B, Gielerak G.   +9 more
europepmc   +1 more source

Prolactinoma Resection in a Transgender Woman on Gender-affirming Hormone Therapy. [PDF]

JCEM Case Rep
Gersey ZC, Vargas AF, Leung JH, Fazeli PK, Zenonos GA, Gardner PA.   +5 more
europepmc   +1 more source